Kailera Therapeutics Inc
KLRA
NASDAQ
Biotechnology
$17.94
USD
-0.03 (-0.17%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.46B
Volume 336.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
KOD | Kodiak Sciences Inc | $2.53B | - | - | - | |
BCRX | BioCryst Pharmaceuticals Inc | $2.52B | - | +68.7% | - | |
KLRA | Kailera Therapeutics Inc | $2.46B | - | - | - | |
SLS | Sellas Life Sciences Group Inc | $2.46B | - | - | - | |
CDNA | CareDx Inc | $2.45B | 22.08 | +34.4% | - | |
COAG | Hemab Therapeutics Holdings Inc | $2.33B | - | - | - | |
MLYS | Mineralys Therapeutics Inc | $2.31B | - | - | - | |
VCEL | Vericel Corp | $2.26B | 93.45 | +22.9% | - | |
PVLA | Palvella Therapeutics Inc | $2.24B | - | -97.2% | - | |
VERA | Vera Therapeutics, Inc | $2.16B | - | - | - |
Top Peer by Growth
BioCryst Pharmaceuticals Inc
+68.7% YoY Revenue
Lowest P/E Ratio
CareDx Inc
22.08x P/E
Best 1-Year Return
Sellas Life Sciences Group Inc
+697.4% Return